We are live on ! Find out more
KIN

Kindred Biosciences, Inc.
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

Back to rankings

72 hedge funds and large institutions have $177M invested in Kindred Biosciences, Inc. in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 30 increasing their positions, 12 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 12

4% less funds holding

Funds holding: 75 → 72 (-3)

20% less capital invested

Capital invested by funds: $221M → $177M (-$44.1M)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

Holders
72
Holders Change
-3
Holders Change %
-4%
% of All Funds
1.58%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
30
Reduced
12
Closed
10
Calls
$397K
Puts
–
Net Calls
+$397K
Net Calls Change
-$775K

Top Buyers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
+$4.55M
2
Allianz Asset Management
Allianz Asset Management
Germany
+$2.12M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.28M
4
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
+$1.04M
5
Goldman Sachs
Goldman Sachs
New York
+$955K

Top Sellers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
-$6.91M
2
RCMNY
Rubric Capital Management (New York)
New York
-$2.5M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.37M
4
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
-$1.27M
5
Millennium Management
Millennium Management
New York
-$900K
Name Holding Trade Value Shares
Change 		Change in
Stake
PWAM
1
Park West Asset Management
California
$46.2M – – –
BlackRock
2
BlackRock
New York
$16.8M +$426K +58,098 +2%
AI
3
Ariel Investments
Illinois
$13.1M -$6.91M -942,023 -33%
Vanguard Group
4
Vanguard Group
Pennsylvania
$12.9M +$1.28M +175,120 +10%
Morgan Stanley
5
Morgan Stanley
New York
$12.5M -$602K -82,045 -4%
Adage Capital Partners
6
Adage Capital Partners
Massachusetts
$11.3M – – –
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$9.16M +$65.2K +8,890 +0.7%
Renaissance Technologies
8
Renaissance Technologies
New York
$8.26M +$141K +19,200 +2%
Ameriprise
9
Ameriprise
Minnesota
$7.16M +$4.55M +620,418 +146%
GIM
10
Granahan Investment Management
Massachusetts
$5.08M +$301K +40,997 +6%
Allianz Asset Management
11
Allianz Asset Management
Germany
$4.95M +$2.12M +288,404 +67%
State Street
12
State Street
Massachusetts
$4.42M +$148K +20,202 +3%
GAI
13
General American Investors
New York
$3.39M – – –
Geode Capital Management
14
Geode Capital Management
Massachusetts
$3.13M +$189K +25,829 +6%
Northern Trust
15
Northern Trust
Illinois
$3.11M +$170K +23,129 +5%
Wells Fargo
16
Wells Fargo
California
$1.46M +$230K +31,332 +17%
Goldman Sachs
17
Goldman Sachs
New York
$988K +$955K +130,280 +940%
DGHMC
18
Dalton, Greiner, Hartman, Maher & Co
New York
$971K +$1.04M +141,800 New
SIA
19
Sit Investment Associates
Minnesota
$920K +$275K +37,525 +39%
UBS Group
20
UBS Group
Switzerland
$827K +$293K +39,958 +49%
N
21
Nuveen
North Carolina
$816K +$34.2K +4,663 +4%
PVAM
22
Pacific View Asset Management
California
$773K – – –
Bank of New York Mellon
23
Bank of New York Mellon
New York
$754K -$17.6K -2,396 -2%
PPA
24
Parametric Portfolio Associates
Washington
$668K +$452K +61,684 +172%
Charles Schwab
25
Charles Schwab
California
$596K – – –
1
2 3 4

KIN Hedge Fund Activity: Q3 2019 in Review

72 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q3 2019, worth a combined $177M — down 20% from $221M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of KIN and 7 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 30 added.

The largest buyer was Ameriprise, adding an estimated $4.55M. The largest seller was Ariel Investments, cutting an estimated $6.91M.

  • 72 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q3 2019, down from 75 in Q2 2019.
  • Funds reported $177M of Kindred Biosciences, Inc. stock for Q3 2019, down 20% quarter-over-quarter.
  • 7 funds opened new Kindred Biosciences, Inc. positions in Q3 2019 and 10 closed out, a net change of -3 holders.
  • The largest Kindred Biosciences, Inc. buyer in Q3 2019 was Ameriprise, an estimated $4.55M added.
  • The largest Kindred Biosciences, Inc. seller in Q3 2019 was Ariel Investments, an estimated $6.91M sold.

Based on aggregated 13F filings for Q3 2019.